Healthcare provider profile · identity verified

Malgorzata E Cywinska, MD

Internal Medicine · TAUNTON, MA · NPI 1497771091

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	518	125
Atorvastatin Calcium	Atorvastatin Calcium	399	120
Omeprazole	Omeprazole	329	91
Metoprolol Succinate	Metoprolol Succinate	247	75
Losartan Potassium	Losartan Potassium	205	63
Hydrochlorothiazide	Hydrochlorothiazide	200	66
Atenolol	Atenolol	194	47
Rosuvastatin Calcium	Rosuvastatin Calcium	193	63
Lisinopril	Lisinopril	190	57
Amlodipine Besylate	Amlodipine Besylate	179	65
Gabapentin	Gabapentin	174	45
Lorazepam	Lorazepam	163	33
Alprazolam	Alprazolam	157	38
Pantoprazole Sodium	Pantoprazole Sodium	157	36
Albuterol Sulfate Hfa	Albuterol Sulfate	154	50
Pravastatin Sodium	Pravastatin Sodium	150	43
Metformin Hcl	Metformin Hcl	124	32
Trazodone Hcl	Trazodone Hcl	122	36
Ibuprofen	Ibuprofen	121	35
Tramadol Hcl	Tramadol Hcl	118	27
Ezetimibe	Ezetimibe	114	36
Furosemide	Furosemide	108	34
Famotidine	Famotidine	107	35
Escitalopram Oxalate	Escitalopram Oxalate	103	32
Montelukast Sodium	Montelukast Sodium	95	29
Eliquis	Apixaban	92	23
Citalopram Hbr	Citalopram Hydrobromide	90	28
Sertraline Hcl	Sertraline Hcl	90	27
Simvastatin	Simvastatin	88	27
Alendronate Sodium	Alendronate Sodium	84	24
Lovastatin	Lovastatin	82	19
Amitriptyline Hcl	Amitriptyline Hcl	78	16
Glimepiride	Glimepiride	76	22
Fluticasone Propionate	Fluticasone Propionate	74	24
Duloxetine Hcl	Duloxetine Hcl	71	16
Celecoxib	Celecoxib	70	27
Allopurinol	Allopurinol	65	17
Spironolactone	Spironolactone	64	21
Clonazepam	Clonazepam	60	11
Prednisone	Prednisone	60	35
Zolpidem Tartrate	Zolpidem Tartrate	59	16
Diclofenac Sodium	Diclofenac Sodium	57	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	16
Ozempic	Semaglutide	56	13
Tizanidine Hcl	Tizanidine Hcl	55	16
Metformin Hcl Er	Metformin Hcl	54	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	13
Metoprolol Tartrate	Metoprolol Tartrate	50	14
Trulicity	Dulaglutide	49	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	49	11
Potassium Chloride	Potassium Chloride	48	17
Azithromycin	Azithromycin	46	36
Buspirone Hcl	Buspirone Hcl	42	13
Fluoxetine Hcl	Fluoxetine Hcl	42	12
Nystatin	Nystatin	42	suppressed
Januvia	Sitagliptin Phosphate	41	suppressed
Ropinirole Hcl	Ropinirole Hcl	41	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	11
Hydroxyzine Hcl	Hydroxyzine Hcl	39	suppressed
Valacyclovir	Valacyclovir Hcl	39	11
Carvedilol	Carvedilol	38	11
Fluconazole	Fluconazole	35	19
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	34	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Baclofen	Baclofen	33	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	19
Bumetanide	Bumetanide	31	suppressed
Meclizine Hcl	Meclizine Hcl	31	15
Clonidine Hcl	Clonidine Hcl	30	suppressed
Methylprednisolone	Methylprednisolone	30	28
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	29	suppressed
Meloxicam	Meloxicam	29	suppressed
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	20
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Mupirocin	Mupirocin	24	14
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Glipizide	Glipizide	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	15
Memantine Hcl	Memantine Hcl	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Primidone	Primidone	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	14
Tradjenta	Linagliptin	20	suppressed
Diazepam	Diazepam	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Valsartan	Valsartan	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Labetalol Hcl	Labetalol Hcl	18	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	18	suppressed
Rybelsus	Semaglutide	18	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	16	suppressed
Clopidogrel	Clopidogrel Bisulfate	16	suppressed
Colestipol Hcl	Colestipol Hcl	16	suppressed
Estradiol (Twice Weekly)	Estradiol	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Ibandronate Sodium	Ibandronate Sodium	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Fenofibrate	Fenofibrate,micronized	15	suppressed
Fentanyl	Fentanyl	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Praluent Pen	Alirocumab	15	suppressed
Temazepam	Temazepam	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Cephalexin	Cephalexin	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Sodium Bicarbonate	Sodium Bicarbonate	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Estradiol	Estradiol	13	suppressed
Glyburide	Glyburide	13	suppressed
Lactulose	Lactulose	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Calcium Acetate	Calcium Acetate	12	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Naproxen	Naproxen	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error